胎监联合脐血流S/D比值预测胎儿宫内窘迫的临床意义  

Clinical significance of fetal heart monitoring and umbilical blood flow S/D ratio on prediction of fetal distress

作　　者：阙贵珍[1] 雷巧茹[1] 何金杏 司徒文慈[1] 

机构地区：[1]广东省开平市中心医院妇产科,广东开平529300

出　　处：《中国医药科学》2015年第10期65-67,共3页China Medicine And Pharmacy

摘　　要：目的：研究胎监联合脐血流 S/D 比值在临床方面预测胎儿宫内窘迫的临床意义。方法对我院2013年7月～2014年7月收治的80例孕妇在妊娠30周时对其进行常规的脐血流 S/D 比值的记录和胎心监护结果检测，并比较新生儿 Apgar 评分，对宫内窘迫进行诊断并比较。结果监测脐血流 S/D 比值中的反应型和 S/D ＜3的孕妇中，其胎儿宫内窘迫的发生率为2.94%（2/68），无反应型和 S/D ＜3的孕妇其胎儿宫内窘迫的发生率为50.00%（1/2），对两组进行比较差异具有统计学意义（ P ＜0.01），无反应型和 S/D ＜3的孕妇其胎儿宫内窘迫的发生率为50.00%（1/2），反应型和 S/D ≥3的孕妇其胎儿宫内窘迫的发生率是25.00%（1/4），通过与无反应型及 S/D ≥3进行比较，差异具有统计学意义（P ＜0.01）。无反应型和 S/D ≥3的6例随后均确定是胎儿宫内窘迫，其符合率是100.00%（6/6）。结论胎监联合脐血流 S/D 比值预测可明显提升诊断胎儿宫内窘迫正确率，对胎儿预后起到改善作用，并且减少围产儿的死亡率。Objective To study the clinical significance of fetal heart monitoring and umbilical blood flow S/D ratio on the prediction of fetal distress. Methods 80 pregnant women with 30 weeks pregnancy, who were received and cured in our hospital from July 2013 to July 2014, were selected to record the umbilical blood flow S/D ratio and to detect the results of fetal heart monitoring. To compare the Apgar score of newborn, to diagnose and compare the fetal distress. Results The incidence of fetal distress in pregnant women with responder of the umbilical blood flow S/D ratio and S/D 〈 3 was 2.94%（2/68）, while which in pregnant women with non-responder and S/D 〈 3 was 50.00%（1/2）, the differences was statically significant（P 〈 0.01）. The differences of the incidence of fetal distress compared pregnant women of non-responder and S/D 〈 3 [50.00%（1/2）] and in pregnant women of responder and S/D ≥ 3[25.00%（1/4）], with pregnant women of non-responder and S/D ≥ 3 [100.00%（6/6）] was statically significant（P 〈 0.01）. Conclusion Fetal heart monitoring and umbilical blood flow S/D ratio prediction could obviously elevate the diagnosis correct rate of fetal distress, has the improvement effect for fetal prognosis, and coud reduce the mortality of perinatal infant.

关 键 词：胎监联合脐血流 预测 胎儿窘迫 

分 类 号：R714.5[医药卫生—妇产科学]